Coagulo Medical Technologies has developed a portable precision-medicine coagulation management platform capable of pinpointing abnormalities across the entire clotting cascade. The firm's technology combines an entirely new set of patent-pending coagulation assays, cutting-edge microfluidic technology and proprietary data analytics and digital connectivity. Coaguloâs new point-of-care testing platform is the first of its kind to deliver accessible and personalized diagnosis and management of all coagulation-related diseases. The platform offers the following benefits: Requires just drops of whole blood, Clinically-actionable, just-in-time information (results within 10 minutes), Portable and fully-automated reader, Can perform 20+ tests simultaneously, Only test that pinpoints the exact coagulation factor that is inhibited or deficient, Quantifies the effect of the deranged coagulation factor on coagulation time, Connectivity allows for trend monitoring and treatment optimization, Ensures better health outcomes at lower cost
